Back to results
US 10,870,887 B2Granted
Mutations in SPTLC2 gene associated with sensory neuropathy
AssigneesVib Vzw, Universiteit Antwerpen, University of Zurich, Medical University of Graz
InventorsAnnelies Rotthier, Vincent Timmerman, Michaela Auer-Grumbach, Thorsten Hornemann
Life of this patent
Estimating the term…
Abstract
Described are methods and kits for identifying a subject at risk of, or having, a sensory neuropathy related disease, such as sensory neuropathies. In particular, the disclosure is based on the determination of mutations in the SPTLC2 gene causing sensory neuropathies.
Claims6
A nucleic acid probe comprising a fragment of a SPTLC2 sequence or the complementary sequence thereof, wherein the SPTLC2 sequence has the sequence of SEQ ID NO:
- 2, and comprises a mutation in at least one nucleotide position corresponding to a position selected from the group consisting of 1145, 1075, and 1510 relative to the ATG start codon beginning at position 189 of SEQ ID NO:2;
- and
- wherein the nucleic acid probe hybridizes to the variant SPTLC2 sequence but not to the wild type SPTLC2 sequence, wherein the nucleic acid probe is 25 to 100 nucleotides in length, and wherein the nucleic acid probe is detectably labeled with a fluorescent, chemiluminescent, enzymatic, radioactive, or chemical label.
Dependencies are inferred from the claim text.